Product image of Linezolid Accord (Linezolid) supplied by GNH India

Linezolid Accord

Active Ingredient:
Linezolid
Origin:
EU

Linezolid Accord (Linezolid)

Linezolid, the active ingredient in Linezolid Accord, is an oxazolidinone antibiotic presented as an oral dosage form for systemic use. It is employed to treat infections caused by resistant Gram‑positive bacteria, including MRSA and VRE, in adult patients.

GNH India supplies Linezolid Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality assurance, regulatory compliance, and reliable logistics for critical antibacterial therapies.

Manufacturer / TM Owner

Accord Healthcare B.V.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Linezolid is an oxazolidinone antibiotic indicated for serious Gram‑positive bacterial infections.

  • Methicillin‑resistant Staphylococcus aureus (MRSA) infections: eradication of resistant strains and clinical resolution.
  • Vancomycin‑resistant Enterococcus (VRE) infections: effective bacterial clearance where other agents fail.
  • Community‑acquired and hospital‑acquired pneumonia: treatment of severe pneumonic episodes caused by susceptible organisms.
  • Skin and soft‑tissue infections: resolution of cellulitis, abscesses and wound infections due to resistant Gram‑positive pathogens.

How It Works

  • Linezolid inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, preventing formation of the initiation complex. This action blocks the translation process, halting bacterial growth and leading to bacteriostatic activity against susceptible Gram‑positive organisms.

Side Effects

Linezolid may cause a range of adverse reactions, from mild to severe.

Common Side Effects

  • Nausea: transient gastrointestinal discomfort.
  • Diarrhea: loose stools, often self‑limiting.
  • Headache: mild to moderate intensity.
  • Metallic taste: altered taste perception.
  • Vomiting: occasional episodes.
  • Rash: mild skin irritation.

Serious or Rare Side Effects

  • Thrombocytopenia: significant drop in platelet count.
  • Peripheral neuropathy: numbness or tingling in extremities.
  • Optic neuropathy: visual disturbances, potentially irreversible.
  • Serotonin syndrome: risk when combined with serotonergic agents.
  • Lactic acidosis: metabolic disturbance requiring urgent care.
  • Myelosuppression: bone‑marrow suppression affecting blood cell production.

Precautions & Warnings

Before prescribing Linezolid, clinicians should consider several safety aspects.

  • Renal impairment: monitor renal function and adjust therapy as needed.
  • Hepatic impairment: assess liver enzymes regularly during treatment.
  • Concomitant serotonergic agents: avoid or closely monitor for serotonin syndrome.
  • Prolonged therapy (>14 days): perform periodic complete blood counts.
  • Pregnancy: use only if potential benefit justifies potential risk to the fetus.
  • Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Linezolid interacts with several drug classes; awareness of interaction severity guides clinical decisions.

Major Interactions (Avoid)

  • Selective serotonin reuptake inhibitors (SSRIs): heightened risk of serotonin syndrome.
  • Monoamine oxidase inhibitors (MAOIs): potential for severe serotonergic effects.
  • Rifampicin: induces metabolism, markedly reducing linezolid exposure.
  • Erythromycin: may increase linezolid plasma concentrations.

Moderate Interactions (Monitor Closely)

  • Warfarin: possible increase in INR, requiring coagulation monitoring.
  • Phenytoin: may lower linezolid levels, affecting efficacy.
  • Tizanidine: enhanced sedative effect, necessitating dose adjustment.

Frequently Asked Questions

Linezolid Accord contains the antibiotic linezolid and is used to treat serious infections caused by resistant Gram‑positive bacteria, such as MRSA, VRE, certain types of pneumonia, and skin or soft‑tissue infections. It is prescribed when other antibiotics are ineffective.

Linezolid works by binding to the bacterial 50S ribosomal subunit, blocking the formation of the initiation complex needed for protein synthesis. This inhibition stops bacterial growth, providing a bacteriostatic effect against susceptible Gram‑positive organisms.

The specific dosage and treatment duration for Linezolid Accord are determined by the prescribing clinician based on the infection type, severity, patient weight, renal and hepatic function, and local guidelines. Patients should follow the prescriber’s instructions exactly.

Safety data for linezolid in pregnancy and lactation are limited. It should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To order Linezolid Accord, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Linezolid belongs to the oxazolidinone class and offers oral bioavailability, making it useful when intravenous therapy is not feasible. Compared with glycopeptides like vancomycin, linezolid provides effective coverage against MRSA and VRE without the need for serum level monitoring, though each agent has distinct safety profiles.

Linezolid Accord should be stored at ambient temperature, below 25 °C, in its original container to protect it from moisture and light. Keep the product out of reach of children and avoid storing in humid environments such as bathrooms.

Linezolid Accord is administered orally, typically as a tablet taken with or without food. The exact dosing schedule is prescribed by the treating physician and should be adhered to for the full prescribed course, even if symptoms improve earlier.

Serious risks include thrombocytopenia, peripheral and optic neuropathy, serotonin syndrome when combined with serotonergic drugs, and rare cases of lactic acidosis or myelosuppression. Patients should be monitored regularly for blood‑count changes and neurological symptoms during therapy.

Linezolid Accord is contraindicated in patients with known hypersensitivity to linezolid or any component of the formulation. Caution is advised for individuals taking serotonergic medications, those with existing severe bone‑marrow suppression, or patients with uncontrolled hypertension.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Linezolid

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT